These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2052527)
1. Sites of first-pass bioactivation (hydrolysis) of orally administered zofenopril calcium in dogs. Morrison RA; Burkett DE; Arnold ME; D'Arienzo CJ; Weinstein SH Pharm Res; 1991 Mar; 8(3):370-5. PubMed ID: 2052527 [TBL] [Abstract][Full Text] [Related]
2. Relative contribution of the gut, liver, and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs. In vivo and in vitro studies. Morrison RA; Singhvi SM; Peterson AE; Pocetti DA; Migdalof BH Drug Metab Dispos; 1990; 18(2):253-7. PubMed ID: 1971582 [TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme. DeForrest JM; Waldron TL; Krapcho J; Turk C; Rubin B; Powell JR; Cushman DW; Petrillo EW J Cardiovasc Pharmacol; 1989 Jun; 13(6):887-94. PubMed ID: 2484083 [TBL] [Abstract][Full Text] [Related]
4. Disposition of zofenopril calcium in healthy subjects. Singhvi SM; Foley JE; Willard DA; Morrison RA J Pharm Sci; 1990 Nov; 79(11):970-3. PubMed ID: 2292772 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of zofenopril in healthy volunteers. Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Tettamanti RA; Crivelli F; Uhr MR; Ismaili S; Giusti A Arzneimittelforschung; 1999 Dec; 49(12):992-6. PubMed ID: 10635443 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers. Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Giusti A; Uhr MR Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965 [TBL] [Abstract][Full Text] [Related]
7. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
8. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril. Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764 [TBL] [Abstract][Full Text] [Related]
9. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection. Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329 [TBL] [Abstract][Full Text] [Related]
10. Comparing different treatment schedules of Zomen (zofenopril). Bălan H; Popescu E; Angelescu G Rom J Intern Med; 2011; 49(1):75-84. PubMed ID: 22026256 [TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122 [TBL] [Abstract][Full Text] [Related]
12. Assay of zofenopril and its active metabolite zofenoprilat by liquid chromatography coupled with tandem mass spectrometry. Dal Bo L; Mazzucchelli P; Marzo A J Chromatogr B Biomed Sci Appl; 2000 Dec; 749(2):287-94. PubMed ID: 11145066 [TBL] [Abstract][Full Text] [Related]
13. The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig. Tio RA; de Langen CD; de Graeff PA; van Gilst WH; Bel KJ; Wolters KG; Mook PH; van Wijngaarden J; Wesseling H Cardiovasc Drugs Ther; 1990 Jun; 4(3):695-703. PubMed ID: 2076380 [TBL] [Abstract][Full Text] [Related]
14. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Westlin W; Mullane K Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109 [TBL] [Abstract][Full Text] [Related]
15. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Cushman DW; Wang FL; Fung WC; Harvey CM; DeForrest JM Am J Hypertens; 1989 Apr; 2(4):294-306. PubMed ID: 2706094 [TBL] [Abstract][Full Text] [Related]
17. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party. Ambrosioni E; Borghi C; Magnani B Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. Sun Y; Mendelsohn FA J Cardiovasc Pharmacol; 1991 Oct; 18(4):478-86. PubMed ID: 1724523 [TBL] [Abstract][Full Text] [Related]
19. Newer ACE inhibitors. A look at the future. Salvetti A Drugs; 1990 Dec; 40(6):800-28. PubMed ID: 2078997 [TBL] [Abstract][Full Text] [Related]
20. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]